US Physical Therapy Inc (USPH): Analyst Median Target

Brandmark of U.S. Physical Therapy (USPH)

The U.S. Physical Therapy (USPH) healthcare sector is susceptible to raw material logistics disruptions and international patenting complexities stemming from conflicts. This price chart clearly demonstrates the asset's dynamics, with a value of 106.26. The business generates revenue by expanding its network of physical therapy centers, where management is prioritizing partnerships, staff loyalty, and cost optimization to increase shareholder payouts.

US Physical Therapy (USPH) - Analyst Consensus Forecast from 07/04/2022 to 11/11/2026
Brand item of U.S. Physical Therapy, Inc.

Portfolio managers are closely monitoring the operational efficiency of U.S. Physical Therapy (USPH). This metric represents the weighted average of target prices from the expert community, reflecting the business's fundamental value. The price action of the analysts' target price indicator helps identify market imbalances relative to the real-time valuation. This is critical for the clinic network, as forecasts account for expansion rates and insurance reimbursements. Comparing the market price with this chart confirms the stability of the issuer's long-term positions.

Competing companies

Analyst Consensus Forecast hcahealthcare.com (HCA)|Price Target Chart Tenet Healthcare Corporation THC|Analyst Median Target Fresenius Medical Care AG (FMS)|SOLV - Price Target Chart|Forecast Levels Chart EHC|UHS: Analyst Consensus Forecast|davita.com - Fair Value Consensus|Consensus Target RDNT|OPCH (Option Care) - Analyst Forecast Prices|Price Target Chart Surgery Partners Corp (SGRY)|PINC (Premier Health) - Fair Value Consensus|Analyst Consensus Forecast EYE (National Vision Holdings)|progyny.com (PGNY) - Average Forecast Price|Ardent Health Partners - Analyst Consensus Forecast|SEM - Analyst Consensus Forecast|ASTH (Apollo Medical Holdings) - Consensus Target|MD: Analyst Forecast Prices|Price Target Chart The Pennant Group, Inc.|Consensus Target organogenesis.com (ORGO)|Analyst Consensus Forecast NUTX|AUNA - Average Forecast Price|Price Target Chart sbc-holdings.com SBC|EOLS: Broker Consensus Forecast|CYH: Consensus Target|The Beauty Health - Analyst Forecast Prices|MDWD (mediwound.com) - Consensus Target|Biote (BTMD) - Analyst Consensus Forecast|Consensus Target JYNT|DocGo, Inc (DCGO) - Analyst Median Target|Price Target Chart P3 Health Partners Inc. (PIII)|Analyst Median Target Gain Therapeutics Inc.|EUDA Health - Consensus Target|Analyst Median Target Basel Medical (BMGL)|CLGN: Consensus Target|Fair Value Consensus CUPR (Cuprina Holdings Limited)|Concord Medical Services (CCM) - Price Target Chart|Forecast Levels Chart AMS (ashs.com)|MRM (MEDIROM Healthcare Group) - Analyst Consensus Forecast|ALBT: Fair Value Consensus|Consensus Target DHAI (DIH Holding US Inc.)|XAGE - Average Forecast Price|Price Target Chart NewGenIvf Group Limited NIVF|Analyst Median Target ATI Physical Therapy Inc. (ATIP)|CareMax - Analyst Consensus Forecast|Analyst Median Target Kindly MD Inc KDLY|MODV: Analyst Consensus Forecast|Consensus Target Novo Integrated Sciences Corp|SSY (SunLink Health Systems Inc.) - Analyst Consensus Forecast|Analyst Consensus Forecast imacholdings.comm